Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-29
1995-09-26
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514885, A61K 3147
Patent
active
054534313
ABSTRACT:
The present invention provides methods of treating graft-versus-host disease comprising administering to a patient having graft-versus-host disease an effective mount of hydroxychloroquine. The present invention aim provides a method of suppressing alloreactivity arising from reactions of donor T lymphocytes against recipient cells comprising administering to said cells an amount of hydroxychloroquine effective to suppress such alloreaetivity.
REFERENCES:
patent: 2546658 (1951-03-01), Surrey
patent: 4419352 (1983-12-01), Cox et al.
patent: 4657763 (1987-04-01), Finkelstein
patent: 4968702 (1990-11-01), Poletto et al.
patent: 5242687 (1993-09-01), Tykoinski et al.
patent: 5262424 (1993-11-01), Kao
patent: 5314894 (1994-05-01), Seder et al.
patent: 5330993 (1994-07-01), Armistead et al.
Davis William J.
Hohenschutz Liza D.
Raymond Richard L.
LandOfFree
Use of hydroxychloroquine for treatment of graft-versus-host dis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hydroxychloroquine for treatment of graft-versus-host dis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hydroxychloroquine for treatment of graft-versus-host dis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1552009